LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 106 of 166
Next
>>
>
2626 to 2650 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	Y39983	1.11	uM	LJP6	72	hr	1097	3260	3673	0.8873	0.8663
BT-20	Y39983	3.33	uM	LJP6	72	hr	1097	2903	3673	0.7905	0.7468
BT-20	Y39983	10	uM	LJP6	72	hr	1097	1520	3673	0.4137	0.2051
BT-20	Nintedanib	0.04	uM	LJP6	72	hr	1097	3560	3673	0.9695	0.9649
BT-20	Nintedanib	0.12	uM	LJP6	72	hr	1097	3389	3673	0.9223	0.9085
BT-20	Nintedanib	0.37	uM	LJP6	72	hr	1097	2822	3673	0.7683	0.7192
BT-20	Nintedanib	1.11	uM	LJP6	72	hr	1097	2889	3673	0.7865	0.7424
BT-20	Nintedanib	3.33	uM	LJP6	72	hr	1097	2625	3673	0.7148	0.6492
BT-20	Nintedanib	10	uM	LJP6	72	hr	1097	1948	3673	0.5305	0.3897
BT-20	Foretinib	0.04	uM	LJP5	72	hr	1097	4073	3846	1.0589	1.0639
BT-20	Foretinib	0.12	uM	LJP5	72	hr	1097	3635	3846	0.9454	0.9390
BT-20	Foretinib	0.37	uM	LJP5	72	hr	1097	1634	3846	0.4250	0.2458
BT-20	Foretinib	1.11	uM	LJP5	72	hr	1097	1269	3846	0.3307	0.0840
BT-20	Foretinib	3.33	uM	LJP5	72	hr	1097	1303	3846	0.3389	0.0996
BT-20	Foretinib	10	uM	LJP5	72	hr	1097	976	3846	0.2538	-0.0628
BT-20	AZD 5438	0.04	uM	LJP6	72	hr	1097	3015	3673	0.8207	0.7856
BT-20	AZD 5438	0.12	uM	LJP6	72	hr	1097	2250	3673	0.6128	0.5098
BT-20	AZD 5438	0.37	uM	LJP6	72	hr	1097	1456	3673	0.3961	0.1749
BT-20	AZD 5438	1.11	uM	LJP6	72	hr	1097	1022	3673	0.2782	-0.0402
BT-20	AZD 5438	3.33	uM	LJP6	72	hr	1097	761	3673	0.2074	-0.1891
BT-20	AZD 5438	10	uM	LJP6	72	hr	1097	540	3673	0.1470	-0.3343
BT-20	Pelitinib	0.04	uM	LJP5	72	hr	1097	3481	3846	0.9048	0.8920
BT-20	Pelitinib	0.12	uM	LJP5	72	hr	1097	3065	3846	0.7967	0.7625
BT-20	Pelitinib	0.37	uM	LJP5	72	hr	1097	3066	3846	0.7977	0.7653
BT-20	Pelitinib	1.11	uM	LJP5	72	hr	1097	2763	3846	0.7186	0.6658

|<
<<
Previous
Page 106 of 166
Next
>>
>
2626 to 2650 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)